Silverberg Bernstein Capital Management’s Pfizer PFE Stock Holding History

Silverberg Bernstein Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$561K	Buy	23,283 +167	+0.7%	+$4.37K	0.21%	46
2026 Q1	$649K	Sell	23,116 -734	-3%	-$19.5K	0.36%	45
2025 Q4	$594K	Buy	23,850 +2,500	+12%	+$63K	0.34%	45
2025 Q3	$544K	Buy	21,350 +7,500	+54%	+$185K	0.33%	46
2025 Q2	$336K	Buy	13,850 +4,050	+41%	+$94.5K	0.23%	52
2025 Q1	$248K	Buy	9,800 +1,600	+20%	+$41.9K	0.23%	51
2024 Q4	$218K	Sell	8,200 -500	-6%	-$13.6K	0.19%	46
2024 Q3	$252K	Buy	+8,700	New	+$254K	0.23%	46

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Silverberg Bernstein Capital Management's PFE Position: Q2 2026 in Review

Silverberg Bernstein Capital Management increased its Pfizer (PFE) stake by 0.72% in Q2 2026, buying an estimated $4.37K and bringing the position to 23,283 shares worth $561K. The position accounts for 0.21% of the portfolio, ranked #46.

Silverberg Bernstein Capital Management first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $649K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Silverberg Bernstein Capital Management held 23,283 shares of Pfizer worth $561K as of Q2 2026.
Silverberg Bernstein Capital Management bought 167 Pfizer shares in Q2 2026, an estimated $4.37K.
Pfizer made up 0.21% of Silverberg Bernstein Capital Management's portfolio in Q2 2026, its #46 holding.
Silverberg Bernstein Capital Management first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
Silverberg Bernstein Capital Management's Pfizer position peaked at $649K in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Silverberg Bernstein Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.